Indian blanket brownfield ban call brings fresh headwinds for FDI

An Indian Parliamentary panel has recommended a "blanket ban" on foreign direct investment (FDI) in brownfield pharmaceutical projects in the country, claiming "danger" to health and intellectual property rights aspects arising from such investments including access and affordability of medicines, as well as the "elbowing" out of the domestic industry and undue pressures on TRIPS arrangements.